P39 Nutritional assessments in COPD: the respiratory nurse perspective on current practice across the UK

Abstract

(ISW), Chronic Respiratory Disease Questionnaire (CRDQ), MRC Dyspnoea score (MRC) and COPD assessment test (CAT) were measured. Between group differences were compared using ManneWhitney U or unpaired t-test. Results Data are presented as median (25 th , 75 th centiles), and summarised in Abstract P37 table 1. 130 COPD patients from this cohort were taking either an ACE-I (n¼82), ARB (n¼45) or both (n¼3). The groups were matched for gender distribution and longterm oral corticosteroid use. Compared with the control COPD patients, those on ACE-I or ARB were older, had better FEV 1 % predicted but similar ISW, CRDQ, MRC and CAT. However, the patients receiving ACE-I or ARB had significantly higher fat free mass (FFM) and fat free mass index (FFMI).Abstract P37

P37 Muscle mass in COPD patients receiving angiotensin II receptor blockers and ACE-inhibitors

“…Future longitudinal studies and randomised controlled trials are required to further define the effect of ACE-I and ARB in COPD.Introduction and ObjectivesTargeting nutritional status is a key issue in COPD. Studies have shown increased mortality in patients with low BMI 1 which improves following weight gain 2. This study examines whether nutritional status is adequately assessed and acted upon in COPD patients admitted to a DGH.…”